BIT/1RMD (BIT/1RMD)

Borsa Italiana: BIT/1RMD · EUR

€196

-1.60 (-0.8%)· Recorded snapshot

Market cap	31.7B
Revenue (ttm)	4.9B
Net income (ttm)	1.3B
EPS (ttm)	€9.37
P/E (trailing)	20.9x
P/E (forward)	20.7x
Dividend	€1.59 (0.81%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.9B
Net income (ttm): 1.3B
EPS (ttm): €9.37
P/E (trailing): 20.9x
P/E (forward): 20.7x
Market cap: 31.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.7

P25 n/aP50 n/aP75 n/a

Trailing P/E20.9

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC26.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BIT/1RMD indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-10-29
Employees	11,370
Employees change	620
Employees growth	6.21%
Enterprise value	EUR 31.1B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1989
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US7611521078
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Market cap	EUR 31.7B
Next earnings date	2026-10-29
Price	EUR 196.00
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-02
Symbol	bit/1RMD
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.58x
Average P/E ratio (3Y)	26.06x
Average P/E ratio (5Y)	34.94x
Earnings yield	4.78%
EV/Earnings	23.31x
EV/EBIT	17.97x
EV/EBITDA	16.12x
EV/FCF	21.53x
EV/Sales	6.13x
FCF / EV yield	4.65%
FCF yield	4.56%
Forward P/E	20.73x
Graham number	81.4176
Graham upside	-58.46%
Lynch fair value	EUR 206.38
Lynch upside	5.3%
P/(FCF - SBC) ratio	23.41x
P/(OCF - SBC) ratio	21.26x
P/B ratio	5.49x
P/E ratio	20.91x
P/FCF ratio	21.93x
P/OCF ratio	20.03x
P/S ratio	6.4x
Price / tangible book value	11.22x
Price/EBITDA ratio	17.26x
Sector forward P/E	16.78x
Sector P/E	20.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.96%
EBITDA margin	37.07%
Effective tax rate	20.64%
FCF margin	28.42%
Gross margin	61.62%
Operating margin	33.96%
Pretax margin	33.95%
Profit margin	26.94%
Profit per employee	EUR 117,268
Profitable quarters	21
Profitable years	33
Revenue per employee	EUR 435,221
ROA	14%
ROA (5Y)	13.12%
ROCE	25.36%
ROE	24.27%
ROE (5Y)	24.35%
ROIC	26.23%
ROIC (5Y)	22.79%
SBC / revenue	1.85%
Tax / revenue	7.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.67%
EPS growth (Q)	2.39%
EPS growth (QoQ)	-3.55%
EPS growth 10Y	15.4%
EPS growth 3Y	19.64%
EPS growth 5Y	26.34%
EPS growth quarters	10
EPS growth years	5
FCF growth	-0.73%
FCF growth (Q)	-20.6%
FCF growth (QoQ)	-22.47%
FCF growth 3Y	42.2%
FCF growth 5Y	21.07%
Gross profit growth	12.84%
Gross profit growth (Q)	4.83%
Gross profit growth 3Y	13.44%
Gross profit growth 5Y	13.02%
Net income growth	8.75%
Net income growth (Q)	0.98%
Net income growth (QoQ)	-3.84%
Net income growth 3Y	19.28%
Net income growth 5Y	26.27%
Net income growth quarters	10
Net income growth years	5
OCF growth	3.1%
OCF growth (Q)	-15.62%
OCF growth (QoQ)	-17.96%
OCF growth 10Y	12.67%
OCF growth 3Y	37.59%
OCF growth 5Y	19.64%
Operating income growth	13.78%
Operating income growth (Q)	-1.08%
Operating income growth 3Y	18.56%
Operating income growth 5Y	15.91%
Revenue growth	9.85%
Revenue growth (Q)	8.58%
Revenue growth (QoQ)	2.25%
Revenue growth 10Y	11.89%
Revenue growth 3Y	10.21%
Revenue growth 5Y	12.08%
Revenue growth quarters	21
Revenue growth years	32

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -136.8M
Depreciation and amortization	EUR 158M
EBIT	EUR 1.7B
EBITDA	EUR 1.8B
EPS	EUR 9.37
Financing cash flow	EUR -881.5M
Free cash flow	EUR 1.4B
Free cash flow minus SBC	EUR 1.4B
Gross profit	EUR 3B
Income taxes	EUR 346.7M
Investing cash flow	EUR -477.2M
Net borrowing	EUR -9M
Net cash flow	EUR 227.4M
Net income	EUR 1.3B
Operating cash flow minus SBC	EUR 1.5B
Operating income	EUR 1.7B
Revenue	EUR 4.9B
Stock-based compensation	EUR 91.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.92
Book value per share	EUR 39.96
Debt / EBITDA	0.39
Debt / equity	0.13
Debt / FCF	0.5
Goodwill	EUR 2.6B
Long-term assets	EUR 4B
Long-term liabilities	EUR 829.9M
Net cash (debt)	EUR 563.1M
Net cash / market cap	1.78%
Net cash growth	79.88%
Net debt / EBITDA	-0.31
Net debt / equity	-0.1
Net debt / FCF	-0.39
Piotroski F-Score	6
Property, plant and equipment	EUR 660.6M
Shareholders' equity	EUR 5.8B
Tangible book value	EUR 2.8B
Tangible book value per share	EUR 19.56
Total assets	EUR 7.8B
Total cash	EUR 1.3B
Total debt	EUR 722.9M
Total liabilities	EUR 2.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	EUR 3.9B
Current liabilities	EUR 1.3B
Current ratio	3.1
Inventory turnover	2.23
Net working capital	EUR 1.5B
Quick ratio	1.83
Working capital	EUR 2.6B
Working capital turnover	1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.87%
Dividend growth	-19.85%
Dividend growth years	1
Dividend payment date	2026-09-24
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	EUR 1.59
Dividend yield	0.81%
Ex-dividend date	2026-08-19
Last dividend	EUR 0.57
Payout ratio	22.95%
Shareholder yield	1.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 186.89
1D price change	-0.81%
1M price change	-2.83%
1M total return	-2.83%
1W price change	0.49%
1W total return	0.49%
1Y price change	-15.44%
1Y return CAGR	-14.76%
1Y total return	-14.75%
20-day SMA	EUR 195.14
200-day SMA	EUR 194.21
3M price change	10.86%
3M total return	11.19%
50-day SMA	EUR 194.41
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 242.60
52-week high date	2025-10-09
52-week low	EUR 157.90
52-week low date	2026-06-02
6M price change	1.27%
6M total return	1.87%
All-time high	EUR 251.30
All-time high date	2025-08-04
All-time low	EUR 157.90
All-time low date	2026-06-02
Average true range (ATR)	EUR 2.90
Average volume	0.4
Change from 52-week high	-19.21%
Change from 52-week low	24.13%
Change from all-time high	-22.01%
Change from all-time low	24.13%
Change from open	0%
Day's gap	-0.81%
High price	EUR 196.00
Low price	EUR 196.00
Monthly RSI	48.63
Open price	EUR 196.00
Previous close	EUR 197.60
Price vs 150-day SMA	4.87%
Price vs 20-day SMA	0.44%
Price vs 200-day SMA	0.92%
Price vs 50-day SMA	0.82%
Relative volume	15
RSI	50.92
Sharpe ratio	-0.53
Sortino ratio	-0.56
Weekly RSI	52.31
YTD price change	-4.95%
YTD total return	-4.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	139.8M
Shares change (QoQ)	-0.51%
Shares change (YoY)	-0.87%
Shares held by insiders	0.49%
Shares held by institutions	80.41%
Short ratio	9.1 days

Deeper analysis on BIT/1RMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1RMD report

Is a complete BIT/1RMD research report available?

No complete published report is available for bit/1RMD (BIT/1RMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1RMD (BIT/1RMD)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1RMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1RMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1RMD

Frequently asked questions